文档介绍:同步放化疗治疗中晚期宫颈癌
作者:刘少兵,周祖金,陈森,覃瑞萍
【摘要】目的观察化疗联合放疗治疗中晚期宫颈癌的临床疗效和毒副作用。方法 58例中晚期宫颈癌患者随机分成化放组(29例)及单纯放疗组(29例),化放组采用顺铂25mg/m2 d13,静脉点滴,5Fu 350mg/m2 d15静脉点滴,每4周重复,共3个周期,同时进行根治性放疗,化疗第1天开始进行放射治疗。用10MVX线体外全盆照射DT38~40Gy,中间铅挡后照射致宫旁剂量DT50~55Gy,第3周开始行192Ir腔内照射,6Gy/次/天/周,A点剂量6Gy,B点剂量5Gy,共6~7次。单纯放射治疗组仅行单纯放疗,方法同化放组,不行化疗。%%,差异无显著(P>)。%%,差异显著(P<)。放化组3、%、%、%,%、%、%,差异显著(P<),随访5年,%,%,P<。化放组有较明显的骨髓抑制和消化道反应,但患者经治疗后均可耐受。结论化疗联合放疗治疗中晚期宫颈癌可增强疗效,副作用稍增加,但患者能耐受。
【关键词】宫颈癌;同步放化疗;疗效;副作用
Prospective Trial for Concurrent Chemoradiotherapy Treatment in Mediumterm and Advanced Cervical Carcinoma
Abstract:Objective To investigate the clinical curative effects and side effects of chemoradiotherapy for mediumterm and advanced cervical carcinoma. Methods FiftyEight patients of mediumterm and advanced cervical carcinoma ly divided into toradiotherapy groups and only radiotherapy group. Each patients of the chemoradiotherapy group g/m2 ivgtt d13 ,5Fluorouracil,350mg/m2 ivgtt,d15, repeat every 28 days, total 3 cycles. And radiotherapy e time, 10 MVX ray iddle field is shielded by plumbum, continuous radiotherapy to total dose of 50~55 Gy; 192Ir highdoserate after loading unit e for total 6~7 times. The patients of radiotherapy group e dose and same methods. Results The eff